We observed altered gene expression in the hyperexpanded clone at relapse, including increase of CCR7, which might play a role in the emigration of malignant B cells from the brain to the CSF [46], and CD81, which has been identified as a novel immunotherapeutic target for B cell lymphomas [43]. The gene discussed is CD81; the disease is B-cell non-Hodgkin lymphoma.